David M. Knott’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | $10.4M | Hold |
120,225
| – | – | 3.8% | 6 |
|
|
2021
Q2 | $9.8M | Hold |
120,225
| – | – | 3.5% | 7 |
|
|
2021
Q1 | $11.4M | Sell |
120,225
-277,385
| -70% | -$26.2M | 4.89% | 6 |
|
|
2020
Q4 | $24.7M | Hold |
397,610
| – | – | 11.16% | 1 |
|
|
2020
Q3 | $23.6M | Sell |
397,610
-40,075
| -9% | -$2.73M | 13.87% | 1 |
|
|
2020
Q2 | $30.5M | Sell |
437,685
-128,240
| -23% | -$8.13M | 16.67% | 1 |
|
|
2020
Q1 | $25.7M | Hold |
565,925
| – | – | 16.2% | 1 |
|
|
2019
Q4 | $36.8M | Hold |
565,925
| – | – | 14.92% | 1 |
|
|
2019
Q3 | $35.1M | Hold |
565,925
| – | – | 14.76% | 1 |
|
|
2019
Q2 | $40.3M | Buy |
565,925
+14,427
| +3% | +$1.06M | 17% | 1 |
|
|
2019
Q1 | $43.2M | Hold |
551,498
| – | – | 17.24% | 1 |
|
|
2018
Q4 | $46.7M | Hold |
551,498
| – | – | 21.94% | 1 |
|
|
2018
Q3 | $94.4M | Hold |
551,498
| – | – | 30.64% | 1 |
|
|
2018
Q2 | $71.3M | Sell |
551,498
-335,027
| -38% | -$37.4M | 26.72% | 1 |
|
|
2018
Q1 | $91.3M | Sell |
886,525
-336,474
| -28% | -$33.3M | 37.65% | 1 |
|
|
2017
Q4 | $104M | Sell |
1,222,999
-56,355
| -4% | -$4.88M | 41.55% | 1 |
|
|
2017
Q3 | $109M | Sell |
1,279,354
-320,600
| -20% | -$25.4M | 46.45% | 1 |
|
|
2017
Q2 | $121M | Hold |
1,599,954
| – | – | 50.58% | 1 |
|
|
2017
Q1 | $106M | Hold |
1,599,954
| – | – | 50.83% | 1 |
|
|
2016
Q4 | $101M | Hold |
1,599,954
| – | – | 51.04% | 1 |
|
|
2016
Q3 | $102M | Sell |
1,599,954
-323,271
| -17% | -$23.7M | 52.58% | 1 |
|
|
2016
Q2 | $143M | Hold |
1,923,225
| – | – | 32.96% | 1 |
|
|
2016
Q1 | $128M | Hold |
1,923,225
| – | – | 34.23% | 1 |
|
|
2015
Q4 | $130M | Hold |
1,923,225
| – | – | 35.65% | 1 |
|
|
2015
Q3 | $103M | Sell |
1,923,225
-80,150
| -4% | -$4.86M | 29.64% | 1 |
|
|
2015
Q2 | $126M | Hold |
2,003,375
| – | – | 26.09% | 1 |
|
|
2015
Q1 | $96.4M | Hold |
2,003,375
| – | – | 20.76% | 1 |
|
|
2014
Q4 | $66.5M | Hold |
2,003,375
| – | – | 15.68% | 1 |
|
|
2014
Q3 | $58.7M | Hold |
2,003,375
| – | – | 11.17% | 1 |
|
|
2014
Q2 | $77.8M | Hold |
2,003,375
| – | – | 13.96% | 1 |
|
|
2014
Q1 | $84.1M | Sell |
2,003,375
-68,608
| -3% | -$2.86M | 16.07% | 1 |
|
|
2013
Q4 | $68M | Hold |
2,071,983
| – | – | 13.87% | 1 |
|
|
2013
Q3 | $55.9M | Sell |
2,071,983
-256,480
| -11% | -$7.22M | 10.7% | 1 |
|
|
2013
Q2 | $54.3M | Buy |
+2,328,463
| New | +$41.9M | 11.3% | 1 |
|
Other funds holding LGND
David M. Knott's LGND Position: Q3 2021 in Review
David M. Knott held its Ligand Pharmaceuticals (LGND) position steady in Q3 2021 at 120,225 shares worth $10.4M. The position accounts for 3.8% of the portfolio, ranked #6.
David M. Knott first reported a position in LGND in Q2 2013 and has held it in 34 quarters since. The position peaked at $143M in Q2 2016. 207 funds tracked by Wall St. Rank hold LGND as of Q3 2021.
- David M. Knott held 120,225 shares of Ligand Pharmaceuticals worth $10.4M as of Q3 2021.
- David M. Knott left its Ligand Pharmaceuticals share count unchanged in Q3 2021.
- Ligand Pharmaceuticals made up 3.8% of David M. Knott's portfolio in Q3 2021, its #6 holding.
- David M. Knott first reported a position in Ligand Pharmaceuticals in Q2 2013 and has held it in 34 quarters since.
- David M. Knott's Ligand Pharmaceuticals position peaked at $143M in Q2 2016.
- 207 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2021.
Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.